Daisuke Aoki
Expertise in
17
conditions

Daisuke Aoki

Tokyo, JP 
Expertise in
17
conditions
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Daisuke Aoki practices in Tokyo, Japan. Mr. Aoki is highly rated in 17 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy.

His clinical research consists of co-authoring 445 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Inage, 2638522, Japan
Meguro, Japan
Chiba, 2638522, Japan
Akasaka, Japan
Minato, 1078402, Japan
Narita, Japan
Otawara, Japan
Shinjuku, Japan
Noda, 2788510, Japan
Forestry and Forest Products Research Institute
Tsukuba, Japan
Ikoma, 6300192, Japan
Shinjiku, Japan
Nara Institute Of Science And Technology 8916-5 Takayama Cho Ikoma Nara 630-0192 Japan, Nara-shi, 6300192, Japan
Shinanomachi, 1608582, Japan
Awara, Japan
Kumamoto, Japan
Keio, Japan
Japan
St Marianna University School of Medicine
Kawasaki, Japan
Sendai, 9808578, Japan
Higashi-osaka, 5778502, Japan
Nagoya, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Enrollment Status: Active_not_recruiting
Publish Date: January 08, 2025
Intervention Type: Drug
Study Drugs: Bevacizumab, Cisplatin, Carboplatin, Paclitaxel, Atezolizumab
Study Phase: Phase 3
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

445 Total Publications

Controlled Grafting Density of Zwitterionic Polymer Brushes for Enhanced Antifouling Properties of Polymer Particles.
Controlled Grafting Density of Zwitterionic Polymer Brushes for Enhanced Antifouling Properties of Polymer Particles.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: October 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Aoki's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile